Growth Metrics

Ironwood Pharmaceuticals (IRWD) Change in Accured Expenses (2016 - 2026)

Ironwood Pharmaceuticals' Change in Accured Expenses history spans 16 years, with the latest figure at -$318000.0 for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses rose 98.99% to -$318000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $6.2 million, a 130.69% increase, with the full-year FY2025 number at $6.2 million, up 130.69% from a year prior.
  • Change in Accured Expenses hit -$318000.0 in Q4 2025 for Ironwood Pharmaceuticals, down from $10.7 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for IRWD hit a ceiling of $19.5 million in Q2 2024 and a floor of -$31.6 million in Q4 2024.
  • Historically, Change in Accured Expenses has averaged -$1.2 million across 5 years, with a median of $27000.0 in 2021.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 5251.13% in 2022 and later soared 907.04% in 2024.
  • Tracing IRWD's Change in Accured Expenses over 5 years: stood at $4.1 million in 2021, then crashed by 514.41% to -$16.8 million in 2022, then skyrocketed by 82.16% to -$3.0 million in 2023, then plummeted by 952.1% to -$31.6 million in 2024, then surged by 98.99% to -$318000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for IRWD at -$318000.0 in Q4 2025, $10.7 million in Q3 2025, and -$4.4 million in Q2 2025.